Ironwood Pharmaceuticals, Inc. (IRWD) vs Tilray Brands, Inc. (TLRY)
Ironwood Pharmaceuticals, Inc. and Tilray Brands, Inc. are both Drug Manufacturers Specialty & Generic companies. Ironwood Pharmaceuticals, Inc. is the larger, with a market value of $692.4M against $603.0M — 1.1× the size. Tilray Brands, Inc. has negative trailing earnings, so its P/E is not meaningful; Ironwood Pharmaceuticals, Inc. trades at 5.2×. Ironwood Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 26.2% against 11.5%. Ironwood Pharmaceuticals, Inc. has the higher net margin (33.4% vs −13.3%) and the higher return on invested capital (101.6% vs −2.27%). Across the 19 metrics below, Ironwood Pharmaceuticals, Inc. leads on 14 and Tilray Brands, Inc. on 5.
Valuation
Profitability
| Metric | IRWD | TLRY | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 100.00% | 28.45% | 53.94% |
| Operating margin | 60.15% | (6.88%) | 0.00% |
| Net margin | 33.36% | (13.26%) | 0.00% |
| Free cash flow margin | 47.66% | (10.77%) | 0.00% |
| Return on equity | (55.26%) | (7.87%) | (0.40%) |
| Return on assets | 41.35% | (5.52%) | (3.32%) |
| Return on invested capital | 101.61% | (2.27%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack